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ABSTRACT	 	The	aim	of	present	work	is	to	develop	a	fast	disintegrating	solid	oral	dosage	form	of	Metoprolol	succinate.	The	concept	of	fast	dissolving	drug	delivery	system	emerged	from	the	desire	to	provide	patient	with	more	conventional	means	of	taking	their	medication.	Problems	associated	with	conventional	tablets	can	be	re-solved	by	means	of	fast	dissolving	tablets	when	put	on	tongue	these	tablets	disintegrate	and	dissolve	rapidly	in	saliva	without	need	of	drinking	water.	The	faster	the	drug	disintegrates	in	to	solution,	the	quicker	the	absorption	and	onset	of	clinical	effect.	Preformulation	results	reveal	that	the	flow	properties	of	the	active	pharmaceutical	ingredient	were	found	to	be	excellent	as	per	IP	limits.	To	perform	drug-polymer	compati-bility	FT-IR	studies	were	carried	out	and	observed	that	there	was	no	interaction	between	the	APl	and	excip-ients.	Eight	formulations	were	prepared	with	varying	super	disintegrating	agent	ratios	and	were	found	that	as	 the	 level	 of	 super	disintegrating	 agent	 decreased	 the	drug	 release	 rates	were	 found	 to	 be	 increased.	Amongst	all	the	formulations,	formulation	containing	CCS	(F4)	as	super	disintegrant	is	fulfilling	all	the	pa-rameters	satisfactorily.	It	has	shown	excellent	in-vitro	disintegration,	in-vitro	dissolution	compared	to	other	formulations.	The	prepared	tablets	disintegrate	within	few	minutes	without	need	of	water;	thereby	enhance	the	absorption	leading	to	its	increased	bioavailability.	It	was	concluded	that	Fast	Disintegrating	tablets	of	Metoprolol	can	be	prepared	successfully	as	it	satisfies	all	the	criteria	as	a	dispersible	tablet	and	would	be	alternative	 to	 the	currently	available	conventional	 tablets.	Prepared	 formulations	were	stable	during	90	days	storage	period	at	controlled	40°C	and	75%RH.	
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INTRODUCTION	Today	drug	delivery	companies	are	focusing	on	solid	oral	drug	delivery	systems	that	offer	greater	patient	
compliance	 and	 effective	 dosages[1].	 Tablet	 is	 the	most	popular	among	all	dosage	forms	existing	today	because	 of	 its	 convenience	 of	 self-administration,	compactness	and	easy	manufacturing.	Many	patients	find	 it	 difficult	 to	 swallow	 tablets	 and	 hard	 gelatin	capsules	 and	 do	 not	 take	 their	 medication	 as	prescribed.	The	difficulty	is	experienced	in	particular	by	pediatric	and	geriatric	patients,	but	it	also	applies	to	 people	 who	 are	 ill	 in	 bed	 and	 to	 those	 active	working	 patients	 who	 are	 busy	 or	 traveling,	especially	those	who	have	no	access	to	water[2].	Over	a	 decade,	 the	 demand	 for	 development	 of	 oral	disintegrating	 tablets	 (ODTs)	 has	 enormously	increased	as	 it	has	significant	 impact	on	the	patient	compliance.	 	 ODTs	 with	 good	 taste	 and	 flavor	increase	the	acceptability	of	bitter	drugs	by	various	groups	of	population.	Oral	disintegrating	tablets	are	also	 called	 as	 orodispersible	 tablets,	 quick	disintegrating	 tablets,	mouth	dissolving	 tablets,	 fast	disintegrating	 tablets,	 fast	 dissolving	 tablets,	 rapid	dissolving	 tablets,	 porous	 tablets	 and	 rapimelts.	However,	 of	 all	 the	 above	 terms,	 United	 States	pharmacopoeia	(USP)	approved	these	dosage	forms	as	 ODTs[3].	 Recently,	 European	 Pharmacopoeia	 has	used	 the	 term	orodispersible	 tablet	 for	 tablets	 that	
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disperses	readily	and	within	3	min	in	mouth	before	swallowing.	
MATERIALS	AND	METHODS	Metoprolol	 succinate	 was	 a	 gift	 sample	 from	 Cipla	Labs,	Chennai	and	Cross	Carmellose	Sodium,	Sodium	starch	 Glycollate,	 Carbopol,	 Polyvinyl	 pyrrolidone	were	obtained	from	Loba	Chemie,	Mumbai.	All	other	chemicals	used	were	of	analytical	grade.	
Pre	formulation	parameters	
Angle	of	Repose:	The	flow	property	was	determined	by	 measuring	 the	 Angle	 of	 Repose.	 In	 order	 to	determine	the	flow	property,	the	Angle	of	Repose	was	determined.	 It	 is	 the	 maximum	 angle	 that	 can	 be	obtained	 between	 the	 free	 standing	 surface	 of	 a	powder	heap	and	the	horizontal.	Angle	of	repose = 𝑡𝑎𝑛01 ℎ𝑟	Where,		h	=	height	of	a	pile	(2	cm)	r	=	radius	of	pile	base.	
Bulk	density:	Bulk	density	is	ratio	of	given	mass	of	powder	 and	 its	 bulk	 volume.	 Bulk	 density	 was	determined	by	measuring	the	volume	of	known	mass	of	powder	sample	that	has	been	passed	through	the	screen	 in	 to	 graduated	 cylinder	 or	 through	 volume	measuring	apparatus	in	to	cup.	Bulk	density = 𝑀𝑉=	Where	M=	mass	of	the	powder	V0=bulk	volume	of	the	powder.	
Tapped	density:	A	known	quantity	of	powder	was	transferred	 to	 a	 graduated	 cylinder	 and	 volume	V0	was	 noted.	 The	 cylinder	 fixed	 to	 a	 density	determination	apparatus,	tapped	for	500	times	then	reading	 was	 observed.	 The	 density	 is	 achieved	 by	mechanically	 tapped	 by	 a	 measuring	 cylinder	containing	 the	 powder	 sample.	 After	 observing	 the	initial	 volume	 the	 cylinder	 is	 mechanically	 tapped	and	 volume	 reading	 were	 taken	 until	 little	 further	volume	changes	is	observed[4].	Tap	density = 𝑀𝑉@ 	Where	M	=	mass	of	the	powder,	Vr	=	final	tapping	volume	of	the	powder.	
Compressibility	 index	 and	 Hausner	 ratio:	 The	compressibility	 index	 and	 Hausner	 ratio	 may	 be	calculated	using	measured	values	of	bulk	density	and	tapped	density	as	follows:	Compressibility	index	 = 𝑇𝑎𝑝𝑝𝑒𝑑	𝑑𝑒𝑛𝑠𝑖𝑡𝑦𝐵𝑢𝑙𝑘	𝑑𝑒𝑛𝑠𝑖𝑡𝑦 × 100	Hausner	ratio = 𝑇𝑎𝑝𝑝𝑒𝑑	𝑑𝑒𝑛𝑠𝑖𝑡𝑦𝐵𝑢𝑙𝑘	𝑑𝑒𝑛𝑠𝑖𝑡𝑦 	
Drug	excipient	compatibility	studies	
Standard	 calibration	 curve	 of	 the	 metoprolol	
succinate:	 100	 mg	 of	 Metoprolol	 was	 weighed	accurately	into	100	ml	volumetric	flask	and	dissolved	in	 small	 quantity	 of	 pH	 6.8	 Phosphate	 buffer,	 the	volume	 was	 made	 up	 with	 the	 pH	 6.8	 Phosphate	buffer.	 Pipette	 10ml	 of	 the	 solution	 into	 another	100ml	 volumetric	 flask	 and	 the	 volume	 was	 made	with	 the	pH	6.8	Phosphate	buffer	 (i.e.:	100µg/ml	 in	pH	 6.8	 Phosphate	 buffer).	 Aliquots	 of	 standard	solution	 1ml,	 2ml,	 3ml,	 4ml,	 5ml	were	 pipette	 into	10ml	volumetric	flasks.	The	volume	made	up	with	pH	6.8	 Phosphate	 buffer.	 The	 absorbance	 of	 each	concentration	 was	 measured	 at	 223	 nm	 using	 UV-Visible	spectrophotometer	against	pH	6.8	Phosphate	buffer	as	a	blank[5].	
Fourier	Transform	Infrared	Spectroscopy	(FT-IR)		Infrared	 radiation	 can	 be	 worked	 in	 two	 different	ways,	either	the	radiation	is	absorbed	by	the	sample	or	 it	 can	 passed	 through	 the	 sample.	 FT-IR	 results	represent	the	molecular	absorption	and	transmission	of	the	sample	which	gives	a	fingerprint	image	of	the	sample.	 So	 for	 different	 samples	 it	 carries	 unique	spectra	and	gives	the	blue	print	of	 the	sample.	This	characterization	is	very	useful	for	analysis	of	number	of	 samples[7].	 In	 FTIR	 analysis	 sample	 has	 been	analysed	in	the	wave	number	between	4000-400	cm-1.KBr	pallets	is	prepared	for	the	FTIR	analysis.	KBr	is	added	 with	 the	 sample	 and	 finally	 pallet	 has	 been	formed	 and	 submitted	 to	 the	 FTIR	 analysis.	Potassium	 bromide	 (KBr)	 is	 the	 commonest	 alkali	halide	used	in	the	pellets	due	to	its	high	transparency.	FT-IR	 analysis	 can	 be	 used	 for	 the	 identification	 of	unknown	 materials,	 determination	 of	 quality	 and	compatibility	of	the	sample	in	a	mixture.		
Formulation	 of	 Metoprolol	 succinate	 Fast	
Dissolving	Tablets		Micro	crystalline	cellulose,	Crosscarmellose	sodium,	sodium	 starch	 glycolate,	 Crosspovidone,	 and	 PVP	were	 weighed	 and	 sifted	 through	 40	 mesh.	 To	 the	above	 blend	 Metoprolol	 succinate,	 saccharin	 was	added	 and	 sifted	 through	 18	 mesh.	 The	 sifted	material	was	placed	in	poly	bag	and	mixed	for	5	min.	To	 the	 above	 blend	 add	 Magnesium	 stearate	 and	Aerosil,	and	this	lubricated	blend	was	added	to	mint	flavor	and	placed	in	poly	bag	and	mixed	for	2-3	min.	The	 lubricated	 blend	was	 compressed	 using	 8	mm	round	punches[6].																																	
Post	compression	parameters	
Physical	Appearance:	The	general	appearance	of	a	tablet,	 its	 identity	 and	 general	 elegance	 is	 essential	for	consumer	acceptance,	for	control	of	lot-to-lot	uni-formity	 and	 tablet-to-tablet	 uniformity.	 The	 control	of	general	appearance	involves	the	measurement	of	size,	 shape,	 colour,	 presence	 or	 absence	 of	 odour,	taste	etc.	
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Size&	 Shape:	 It	 can	 be	 dimensionally	 described	 &	controlled.	The	thickness	of	a	tablet	is	only	variables.	Tablet	thickness	can	be	measured	by	micro-meter	or	by	 other	 device.	 Tablet	 thickness	 should	 be	 con-trolled	within	a	±	5%	variation	of	standard	value.	
Weight	variation	test:	Twenty	tablets	were	weighed	individually	and	 the	average	weight	was	calculated.	The	 individual	 tablet	weights	are	 then	compared	to	the	average	weight.	Not	more	than	two	tablets	should	differ	in	their	average	weight	by	more	than	percent-ages	stated	in	USP.	No	tablet	must	differ	by	more	than	double	the	relevant	percentage.	
Content	Uniformity:	Randomly	select	30	tablets.	10	of	these	assayed	individually.	The	Tablet	pass	the	test	if	9	of	the10	tablets	must	contain	not	less	than	85%	and	not	more	than	115%	of	the	labeled	drug	content	and	 the	10th	 tablet	may	not	 contain	 less	 than	75%	and	more	than	125%	of	the	labeled	content.	If	these	conditions	are	not	met,	remaining	20	tablets	assayed	individually	 and	none	may	 fall	 outside	 of	 the	 85	 to	115%	range.	
Thickness	and	diameter:	The	thickness	and	diame-ter	of	10	tablets	were	recorded	during	the	process	of	compression	using	vernier	calipers.	
Hardness:	Hardness,	which	is	the	force	required	to	break	the	tablet	is	measured	in	kilograms.	The	small	and	portable	hardness	tester	measures	the	force	re-quired	to	break	the	tablet	when	the	force	generated	by	a	coil	spring	is	applied	diametrically	to	the	tablet.	
Friability:	 A	 number	 of	 tablets	 are	 weighed	 and	placed	 in	 the	 apparatus	where	 they	 are	 exposed	 to	rolling	 and	 repeated	 shocks	 as	 they	 fall	 6	 inches	 in	each	turn	within	the	apparatus.	After	four	minutes	of	this	 treatment	 or	 100	 revolutions,	 the	 tablets	 are	weighed	 and	 the	 weight	 compared	 with	 the	 initial	weight.	The	loss	due	to	abrasion	is	a	measure	of	the	tablet	friability.	The	value	is	expressed	as	a	percent-age.	A	maximum	weight	loss	of	not	more	than	1%	of	the	weight	of	the	tablets	being	tested	during	the	fria-bility	test	is	considered	generally	acceptable	and	any	broken	or	smashed	tablets	are	not	picked.	The	percentage	friability	was	determined	by	the	for-mula:	 %	Friability = (𝑊1 −𝑊Y)𝑊Y × 100	W1	=	Weight	of	tablets	before	test	W2	=	Weight	of	tablets	after	test	
Disintegration	test:	The	U.S.P.	device	to	test	disinte-gration	uses	6	glass	tubes	that	are	open	at	the	top	and	10	mesh	screen	at	the	bottom	end.	To	test	for	disinte-gration	time,	one	tablet	is	placed	in	each	tube	and	the	basket	 rack	 is	 positioned	 in	 a	 1-L	 beaker	 of	water,	simulated	gastric	fluid	or	simulated	intestinal	fluid	at	37	±	20C	such	that	the	tablet	remain	2.5	cm	below	the	surface	of	liquid	on	their	upward	movement	and	not	closer	than	2.5	cm	from	the	bottom	of	the	beaker	in	
their	downward	movement.	Move	the	basket	contain-ing	the	tablets	up	and	down	through	a	distance	of	5-6	cm	at	a	frequency	of	28	to	32	cycles	per	minute.	Float-ing	of	the	tablets	can	be	prevented	by	placing	perfo-rated	 plastic	 discs	 on	 each	 tablet.	 According	 to	 the	test	the	tablet	must	disintegrate	and	all	particles	must	pass	 through	the	10	mesh	screen	 in	 the	 time	speci-fied.	If	any	residue	remains,	it	must	have	a	soft	mass.	If	one	or	two	tablets	fail	to	disintegrate,	the	test	is	re-peated	using	12	tablets[7].	
Disintegration	time:	Uncoated	tablet:	5-30	minutes.	
Coated	tablet:	1-2	hours	
Table 1: Results of Pre-Compression Parameters 
S.No	 Parameter	 Result	
1	 Angle	of	repose	 28.98	±	0.13	
2	 Bulk	density	 0.463	±	0.31	
3	 Tap	density	 0.509	±	0.27	
4	 Compressibility	index	 9.03	±0.63	
5	 Hausner	ratio	 1.09	±	0.12	
Dissolution	studies	The	dissolution	test	was	carried	out	in	USP	Apparatus	Type	II	(paddle)	with	0.1	N	Hydrochloric	acid	as	the	dissolution	medium.	The	 samples	were	drawn	at	5,	10,	15,	20	and	30	min.	Fresh	volume	of	the	medium	were	replaced	with	the	withdrawn	volume	to	main-tain	the	sink	conditions.	Samples	withdrawn	were	an-alyzed	for	the	percentage	of	drug	released.	
Dissolution	Parameters	Dissolution	Appa-ratus	 USP	Apparatus	Type	II	(Paddle)	Dissolution	Medium	 0.1N	Hydrochloric	acid	Volume	 900	ml	Temperature	 37±2°C	Rpm	 50	Sampling	Intervals	(min)	 5,	10,	15,	20	&30min	
RESULTS	AND	DISCUSSION	
Pre-formulation	study:	Weight	variation	has	shown	almost	 similar	 to	 all	 the	 formulations	 as	 the	 total	weight	taken	is	200	mg	for	the	tablets.	Friability	per-centage	varies	according	to	the	concentrations	of	the	super	 disintegrants	 and	 F4	 has	 shown	 the	 value	 of	0.74.	 Hardness	 is	 compared	 all	 the	 formulations	where	F4	has	shown	the	best	result	of	3.82	as	it	gives	the	optimum	hardness	which	 facilitates	 the	disinte-gration	of	oral	disintegration	tablet.	Thickness	meas-ured	using	Vernier	 calipers	which	 varies	 among	 all	the	formulations	and	optimized	formulation	is	F4.		Wetting	time	is	calculated	as	per	the	IP	for	all	the	for-mulations	and	more	 time	 taken	 for	 the	 formulation	F1	 i.e.	22	sec	as	 it	 implies	 to	 the	disintegration	and	dissolution.	Best	 result	 is	obtained	 for	 the	 formula-tion	F4	which	has	shown	15	sec	which	facilitates	the	disintegration.	Assay	is	calculated	for	all	the	formula-tions	 F4	 has	 shown	 the	 good	 result.	 The	 most	 im	
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portant	parameter	which	is	evaluated	for	oral	disin-tegration	 tablet	 is	 disintegration	 time	 which	 com-pared	for	all	the	formulations.	Its	ability	to	perform	effectively	 as	 an	 ODT	 should	 be	 justified	 based	 on	product	performance.	For	such	products,	 the	extent	of	component	solubility	(e.g.,	tablet	residue,	need	for	liquids)	can	influence	the	acceptability	of	the	product	being	labeled	as	an	ODT.	Disintegration	time	for	ODT	generally	ranges	from	few	sec	to	less	than	a	minute.	Dissolution	studies	were	carried	out	for	all	the	formu-lations	a	s	per	IP	and	among	all	the	formulations	F4	formulation	which	 is	 composed	 of	 Crosscarmellose	sodium	as	a	superdisintegrant	has	shown	the	best	re-lease	in	30	sec.	
Table 3: Calibration table of Metoprolol Succinate 
Concentra-
tion(µg/ml) 
Absorbance	at	223	
nm 
2 0.112 
4 0.224 
6 0.312 
8 0.416 
10 0.518 
12 0.614 
14 0.708 
 
Figure 1: Calibration graph of Metoprolol Succinate 
 
Figure 2: FT-IR spectrum of Metoprolol Succinate 
 
Figure 3: FT-IR spectrum of Metoprolol Succinate and MCC 
 
Figure 4: FT-IR spectrum of Metoprolol Succinate and CCS 
 
Figure 5: FT-IR spectrum of Metoprolol Succinate and CP 
 
Figure 6: FT-IR spectrum of Metoprolol Succinate and SSG 
Table 2: Formulation Developmental Trails 
Ingredients (%) F1 F2 F3 F4 F5 F6 F7 F8 
Metoprolol (mg) 25 25 25 25 25 25 25 25 
CCS 5 - - 7.5 10 12.5 - - 
SSG - 5 - - - - 10 - 
CP - - 5 - - - - 10 
Aerosil 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
PVP 5 5 5 5 5 5 5 5 
Sodium saccharin (mg) 5 5 5 5 5 5 5 5 
Magnesium Stearate 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
MCC q.s q.s q.s q.s q.s q.s q.s q.s 
Mint Flavor 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Total (mg) 200 200 200 200 200 200 200 200 
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Figure 7: FT-IR spectrum of Metoprolol Succinate and PVP 
CONCLUSION	Fast	 disintegrating	 Tablets	 of	 Metoprolol	 succinate	using	 super	disintegrating	 agents	were	 found	 to	be	good	 without	 chipping,	 capping	 and	 sticking.	 	 The	drug	content	was	uniform	in	all	 the	formulations	of	tablets	 prepared.	 FT-IR	 studies	 indicated	 that	 the	drug	 is	compatible	with	the	disintegrants.	The	drug	and	super	disintegrating	agent	ratio	was	found	to	in-fluence	the	release	of	drug	from	the	formulations.	As	the	level	of	super	disintegrating	agent	decreased	the	drug	 release	 rates	 were	 found	 to	 be	 increased.		Amongst	all	the	formulations,	formulation	containing	CCS	as	super	disintegrant	is	fulfilling	all	the	parame-ters	satisfactorily.	It	has	shown	excellent	in	vitro	dis-integration,	 in	 vitro	 dissolution,	 compared	 to	 other	formulation.	The	prepared	tablets	disintegrate	within	few	minutes	without	need	of	water;	thereby	enhance	the	absorption	leading	to	its	increased	bioavailability.	It	was	 concluded	 that	 Fast	Disintegrating	 tablets	 of	Metoprolol	can	be	prepared	successfully	as	it	satisfies	all	the	criteria	as	a	dispersible	tablet	and	would	be	al-ternative	to	the	currently	available	conventional	tab-lets.	 Prepared	 formulations	 were	 stable	 during	 90	days	storage	period	at	controlled	40°C	and	75%RH.	
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Table 4: Results of post compression parameters 
Parameters F1 F2 F3 F4 F5 F6 F7 F8 
Weight  
variation 200±0.92 201±0.91 200±0.92 200±0.92 201±0.91 201±0.91 200±0.92 200±0.92 
Friability 0.65 0.59 0.90 0.74 0.70 0.65 0.87 0.64 
Hardness 4.26±0.68 4.12±0.94 4±0.53 3.82±0.54 3.7±0.62 3.6±0.37 3.4±0.37 3.36±0.37 
Thickness 4.32±0.42 4.24±0.36 4.1±0.26 3.93±0.28 3.82±0.62 3.61±0.48 3.42±0.32 3.21±0.26 
Wetting time 38±1.5 28±1.3 22±1.4 15±1.8 32±1.3 34±1.2 33±1.4 26±1.6 
Disintegration 
time 46±1.1 45±1.4 40±1.7 35±1.3 31±2.6 35±3.8 22±4.2 20±1.2 
Assay 93.6±0.99 93.8±0.98 94.2±1.0 98..6±0.91 95.1±0.98 93.2±0.98 93.8±0.92 98.3±092 
Table 5: Dissolution time 
Time F1 F2 F3 F4 F5 F6 F7 F8 
5 89.2 89.8 91.2 91.7 91.9 92.3 92.3 92.9 
10 91.6 91.9 92.6 92.8 93.8 94.2 94.6 94.9 
15 92.2 92.6 92.8 93.1 93.2 94.4 94.6 95.2 
20 94.4 94.6 95.1 95.3 95.6 96.1 96.2 96.3 
25 95.2 95.5 95.8 96.9 96.1 96.3 96.6 98.1 
30 96.2 96.5 96.8 98.9 97.1 97.3 97.6 97.8 
 
